What is the Integral Diagnostics (ASX: IDX) share price?
The IDX share price is $1.94, down 2.02% for the day, based on the latest available ASX market data.
What is Integral Diagnostics's market capitalisation?
Integral Diagnostics has a market capitalisation of $723.7M, making it the 398th-largest security listed on the ASX.
Does Integral Diagnostics pay a dividend?
Yes. IDX has a trailing dividend yield of 1.47%.
What is IDX's P/E ratio?
Integral Diagnostics trades on a trailing price-to-earnings (P/E) ratio of 26.42, based on its current share price and most recent reported earnings.
Is Integral Diagnostics profitable?
Yes. In its most recent reported period (ending 31 Dec 2025), IDX reported revenue of $393.5M and a net profit of $9.0M.
How many IDX shares are on issue?
Integral Diagnostics has approximately 373,066,537 shares on issue, based on its market capitalisation of $723.7M and current share price.
What sector is Integral Diagnostics in?
Integral Diagnostics is classified in the Healthcare sector, within the Medical - Diagnostics & Research industry on the ASX.
When did Integral Diagnostics list on the ASX?
Integral Diagnostics listed on the Australian Securities Exchange on 20 Oct 2015.
